Advertisement

Topics

EMA panel backs orphan drug status for cystic fibrosis drug

06:56 EDT 16 Oct 2018 | SmartBrief

The European Medicines Agency's Committee for Orphan Medicinal Products adopted a positive opinion on orphan drug status for  -More

Original Article: EMA panel backs orphan drug status for cystic fibrosis drug

NEXT ARTICLE

More From BioPortfolio on "EMA panel backs orphan drug status for cystic fibrosis drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...